Cantoni Therapeutics | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

16,821 results for “Cantoni Therapeutics”

Cantoni Therapeutics Secures Funding to Advance Novel NNMT Inhibitor for Obesity Treatment

Edgewise Therapeutics' Sevasemten Shows Promise in Phase 2 Trial for Becker Muscular Dystrophy

Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics

XRHealth Acquires Swing Therapeutics to Expand Digital Therapeutics Portfolio

Valerio Therapeutics Expands Antibody Development Capabilities with Emglev Therapeutics Acquisition

Rise Therapeutics Advances Oral Immunotherapies Across Multiple Phase 1 Trials

Sapience Therapeutics Advances ST316 into Phase 2 Trial for Advanced Solid Tumors

Aileron Therapeutics Rebrands as Rein Therapeutics, Focuses on Fibrosis Therapies

Lexeo Therapeutics Partners with Investors to Launch $40M RNA Cardiac Therapeutics Spinout

DEBRA Research and Nonsense Therapeutics Form ReadOn Therapeutics to Advance Epidermolysis Bullosa Treatments

Page 1 of 884